Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).
Since 2016 we are pleased to call Basel our home of our summer event (we run a sister event in Manchester, UK, in November 2020). Located in the heart of Europe, Basel is a unique Life Science Ecosystem which we are proud to support. BOS Basel 2020 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, to present at BOS Basel 2020
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, will present in the Biologics CMC Outsourcing work-stream at BOS Basel 2020. Her confirmed presentation title is "Agile sourcing strategies for new therapeutic modalities".
CARBOGEN AMCIS Confirm Exhibition Sponsorship at BOS Basel 2020
Bio2Business is delighted to welcome CARBOGEN AMCIS as an Exhibition Sponsor at BOS Basel 2020. CARBOGEN AMCIS, a member of the Dishman Group, provide drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development.
Quality Assistance Confirm Exhibition Sponsorship at BOS Basel 2020
Bio2Business is delighted to welcome Quality Assistance as an Exhibition Sponsor at BOS Basel 2020. Meet their delegates at Booth Number 30. Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.